These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16241993)

  • 1. p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer.
    Ribeiro-Silva A; Ramalho LN; Garcia SB; Brandão DF; Chahud F; Zucoloto S
    Histopathology; 2005 Nov; 47(5):458-66. PubMed ID: 16241993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells.
    Hungermann D; Buerger H; Oehlschlegel C; Herbst H; Boecker W
    BMC Cancer; 2005 Jul; 5():92. PubMed ID: 16050957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?
    Fadare O; Wang SA; Hileeto D
    Hum Pathol; 2008 Mar; 39(3):331-6. PubMed ID: 18261623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporadic invasive breast carcinomas with medullary features display a basal-like phenotype: an immunohistochemical and gene amplification study.
    Rodríguez-Pinilla SM; Rodríguez-Gil Y; Moreno-Bueno G; Sarrió D; Martín-Guijarro Mdel C; Hernandez L; Palacios J
    Am J Surg Pathol; 2007 Apr; 31(4):501-8. PubMed ID: 17414096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokeratin profiles of male breast cancers.
    Ciocca V; Bombonati A; Gatalica Z; Di Pasquale M; Milos A; Ruiz-Orrico A; Dreher D; Folch N; Monzon F; Santeusanio G; Perou CM; Bernard PS; Palazzo JP
    Histopathology; 2006 Oct; 49(4):365-70. PubMed ID: 16978199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD109 expression in basal-like breast carcinoma.
    Hasegawa M; Moritani S; Murakumo Y; Sato T; Hagiwara S; Suzuki C; Mii S; Jijiwa M; Enomoto A; Asai N; Ichihara S; Takahashi M
    Pathol Int; 2008 May; 58(5):288-94. PubMed ID: 18429827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between BRCA1 expression and apoptosis-related biological parameters in sporadic breast carcinomas.
    Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K
    Anticancer Res; 2002; 22(6B):3615-9. PubMed ID: 12552965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
    Kusińska R; Potemski P; Jesionek-Kupnicka D; Kordek R
    Pol J Pathol; 2005; 56(3):107-10. PubMed ID: 16334976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes.
    Kim MJ; Ro JY; Ahn SH; Kim HH; Kim SB; Gong G
    Hum Pathol; 2006 Sep; 37(9):1217-26. PubMed ID: 16938528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors.
    Laakso M; Loman N; Borg A; Isola J
    Mod Pathol; 2005 Oct; 18(10):1321-8. PubMed ID: 15990899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast.
    Grenier J; Soria JC; Mathieu MC; Andre F; Abdelmoula S; Velasco V; Morat L; Besse B; Dunant A; Spielmann M; Delaloge S
    Anticancer Res; 2007; 27(1B):547-55. PubMed ID: 17348440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
    Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
    J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray.
    Williams DJ; Cohen C; To TV; Page AJ; Lawson D; Sussman ZM; Nassar A
    Hum Pathol; 2009 Aug; 40(8):1176-81. PubMed ID: 19368951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor expression in the basal subtype of breast carcinoma.
    Ribeiro-Silva A; Ribeiro do Vale F; Zucoloto S
    Am J Clin Pathol; 2006 Apr; 125(4):512-8. PubMed ID: 16627261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.
    Stein T; Price KN; Morris JS; Heath VJ; Ferrier RK; Bell AK; Pringle MA; Villadsen R; Petersen OW; Sauter G; Bryson G; Mallon EA; Gusterson BA
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6872-9. PubMed ID: 16203777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
    Edwards PC; Bhuiya T; Kelsch RD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of p16, p53, and p63 in colorectal adenomas and adenocarcinomas.
    Carneiro FP; Ramalho LN; Britto-Garcia S; Ribeiro-Silva A; Zucoloto S
    Dis Colon Rectum; 2006 May; 49(5):588-94. PubMed ID: 16575619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell blocks allow reliable evaluation of expression of basal (CK5/6) and luminal (CK8/18) cytokeratins and smooth muscle actin (SMA) in breast carcinoma.
    Delgallo WD; Rodrigues JR; Bueno SP; Viero RM; Soares CT
    Cytopathology; 2010 Aug; 21(4):259-66. PubMed ID: 19843143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.